Search results
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 2 hours agoFollowing a near 60-year technological gap, two vaccines for the prevention of respiratory syncytial...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
Dallas Morning News· 3 days agoShares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its COVID-19 vaccine Comirnaty and...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 2 hours agoSource: Author's elaboration, based on GuruFocus data. Moreover, this financial metric is significantly higher than that of its key competitors such as...
First cancer jab trial finds they 'weaponise immunse system to attack tumours'
The US Sun· 39 minutes agoA NEW mRNA cancer vaccine can reprogram the immune system to attack tumours within 48 hours, a study shows. The first-ever human clinical trial of four adult patients showed the jab helps fight ...
Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR | JD Supra
JD Supra· 1 day agoWe previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, “Moderna”) against BioNTech SE, BioNTech...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 5 days agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
Pfizer, Genmab Get Full FDA Approval for Cervical-Cancer Drug
Morningstar· 2 days agoPfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms of cervical cancer. The companies' drug Tivdak ...
Pfizer, Genmab get full FDA approval for cervical-cancer drug
Market Watch· 2 days agoPfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms of cervical cancer. The companies’ drug Tivdak ...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 5 days agoDive Brief: The Food and Drug Administration on Friday approved a new gene therapy for hemophilia,...
Remembering Joe Rosenberg, a Wall Street Veteran and Man of All Markets
Barrons.com· 1 hour ago“The best companies in the world are now some of the cheapest stocks.” In his final interview with...
